MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Sun, Feb 20, 2022
Feb 20
exercised or converted securities in ALKS
10,096 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +80.00% (+13,322 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.76%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback